43 results on '"Ghalali, Aram"'
Search Results
2. Discovery and Characterization of Ephrin B2 and EphB4 Dysregulation and Novel Mutations in Cerebral Cavernous Malformations: In Vitro and Patient-Derived Evidence of Ephrin-Mediated Endothelial Cell Pathophysiology
3. Disease specific urinary biomarkers in the central nervous system
4. AZIN1 RNA editing alters protein interactions, leading to nuclear translocation and worse outcomes in prostate cancer
5. Lectin-type oxidized LDL receptor-1 as a potential therapeutic target for cerebral cavernous malformations treatment.
6. PTEN and PHLPP crosstalk in cancer cells and in TGFβ-activated stem cells
7. Discovery and Characterization of Ephrin B2 and EphB4 Dysregulation and Novel Mutations in Cerebral Cavernous Malformations: In Vitro and Patient-Derived Evidence of Ephrin-Mediated Endothelial Cell Pathophysiology
8. Nonsurgical mouse model of endometriosis-associated pain that responds to clinically active drugs
9. Supplementary Data S1 from Inhibition of Wnt Signaling in Colon Cancer Cells via an Oral Drug that Facilitates TNIK Degradation
10. Supplementary Data Figure 1 from Atorvastatin Decreases HBx-Induced Phospho-Akt in Hepatocytes via P2X Receptors
11. Data from Atorvastatin Decreases HBx-Induced Phospho-Akt in Hepatocytes via P2X Receptors
12. Supplemental Legends from Atorvastatin Decreases HBx-Induced Phospho-Akt in Hepatocytes via P2X Receptors
13. Data from Inhibition of Wnt Signaling in Colon Cancer Cells via an Oral Drug that Facilitates TNIK Degradation
14. Supplementary Data Figure 2 from Atorvastatin Decreases HBx-Induced Phospho-Akt in Hepatocytes via P2X Receptors
15. Supplementary Figures S1-S9 from CXADR-Mediated Formation of an AKT Inhibitory Signalosome at Tight Junctions Controls Epithelial–Mesenchymal Plasticity in Breast Cancer
16. Supplementary Tables from CXADR-Mediated Formation of an AKT Inhibitory Signalosome at Tight Junctions Controls Epithelial–Mesenchymal Plasticity in Breast Cancer
17. Developing a novel FRET assay, targeting the binding between Antizyme-AZIN
18. Inhibition of Wnt Signaling in Colon Cancer Cells via an Oral Drug that Facilitates TNIK Degradation
19. DIPG-14. Neogenin Knockout Stops the Invasion and Dissemination of Diffuse Intrinsic Pontine Gliomasin vivo.
20. Toluene diisocyanate: Induction of the autotaxin-lysophosphatidic acid axis and its association with airways symptoms
21. Atorvastatin prevents ATP-driven invasiveness via P2X7 and EHBP1 signaling in PTEN-expressing prostate cancer cells
22. RNA editing of AZIN1 increases cellular aggressiveness in prostate cancer
23. Abstract 1822: RNA eding of AZIN1 increases cellular aggressiveness in prostate cancer
24. Human Peripheral Blood Eosinophils Express High Levels of the Purinergic Receptor P2X4
25. Abstract 4888: Nuclear localization of antizyme inhibitor may be a marker for aggressiveness of prostate cancer
26. The Water Extract of Juniperus communis L. Induces Cell Death and Sensitizes Cancer Cells to Cytostatic Drugs through p53 and PI3K/Akt Pathways
27. CXADR-Mediated Formation of an AKT Inhibitory Signalosome at Tight Junctions Controls Epithelial–Mesenchymal Plasticity in Breast Cancer
28. Clusterin enhances migration and invasion of prostate cancer cells through an isoform-specific Akt2/miR-190/PHLPP1 circuit
29. Clusterin enhances AKT2‐mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit
30. Toluene diisocyanate exposure and autotaxin–lysophosphatidic acid signalling
31. Abstract 3854: Antizyme inhibitor editing modulates nuclear localization but not antizyme binding: Implications for prostate cancer
32. Atorvastatin Decreases HBx-Induced Phospho-Akt in Hepatocytes via P2X Receptors
33. Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) and PH domain and leucine-rich repeat phosphatase cross-talk (PHLPP) in cancer cells and in transforming growth factor β-activated stem cells.
34. Clusterin enhances AKT2‐mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit.
35. Abstract 2812: The chemo-prevention effect of statin on hepatocellular carcinoma cell lines
36. Phosphatase and Tensin Homolog Deleted on Chromosome 10 (PTEN) and PH Domain and Leucine-rich Repeat Phosphatase Cross-talk (PHLPP) in Cancer Cells and in Transforming Growth Factor β-Activated Stem Cells
37. Differential role of thiopurine methyltransferase in the cytotoxic effects of 6-mercaptopurine and 6-thioguanine on human leukemia cells
38. Abstract 588: Evidence for a role of a P2X7- EHBP1-Akt axis in prostate carcinogenesis and in statin chemo-prevention
39. Silencing p110β prevents rapid depletion of nuclear pAkt
40. Abstract 1042: Balance between several phosphatases is crucial for statin- and ATP-induced depletion of nuclear pAkt in prostatic cancer cells
41. Purinergic Receptor-mediated Rapid Depletion of Nuclear Phosphorylated Akt Depends on Pleckstrin Homology Domain Leucine-rich Repeat Phosphatase, Calcineurin, Protein Phosphatase 2A, and PTEN Phosphatases
42. Clusterin enhances migration and invasion of prostate cancer cells through an isoform-specific Akt2/miR-190/ PHLPP1 circuit.
43. Inhibition of Wnt Signaling in Colon Cancer Cells via an Oral Drug that Facilitates TNIK Degradation.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.